The aim of the present study was to investigate the intracellular signaling events downstream of the classical estrogen receptors (ESRs) and G protein-coupled estrogen receptor 1 (GPER) involved in regulation of proliferation and apoptosis of rat Sertoli cells, in which we have previously described ESR1, ESR2, and GPER. ESRs play a role in Sertoli cell proliferation, and GPER, but not ESRs, plays a role modulating gene expression involved with apoptosis. The present study shows that 17beta-estradiol (E2) and the GPER-selective agonist G-1 rapidly activate phosphatidylinositol 3-kinase (PIK3)/serine threonine protein kinase (AKT) and cyclic AMP response element-binding (CREB) phosphorylation. E2 and the ESR1-selective agonist 4,4 0 ,4 00 -(4-propyl-(1H)-pyrazole-1,3,5-triyl)trisphenol (PPT) increase the expression of cyclin D1 (CCND1), whereas the ESR2-selective agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN) and G-1 do not change the expression of this protein, suggesting that ESR1 is the upstream receptor regulating Sertoli cell proliferation. E2-or PPT-ESR1, through activation of epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase 3/1 (MAPK3/1) and PIK3 pathways, induces upregulation of CCND1. KG-501, the compound that disrupts the phospho-CREB/CREB binding protein (CBP) complex, does not change E2-or PPT-ESR1-mediated CCND1 expression, suggesting that phospho-CREB/cyclic AMP response element/ CBP is not involved in the expression of this protein. E2-or G-1-GPER, through activation of EGFR/MAPK3/1 and PIK3 pathways, may be involved in the upregulation of antiapoptotic proteins BCL2 and BCL2L2. E2-or G-1-GPER/EGFR/MAPK3/1/ phospho-CREB decreases BAX expression. Taken together, these results show a differential effect of E2-GPER on the CREBmediated transcription of proapoptotic and antiapoptotic genes of the same BCL2 gene family. ESR1 and GPER can mediate the rapid E2 actions in the Sertoli cells, which in turn can modulate nuclear transcriptional events important for Sertoli cell function and maintenance of normal testis development and homeostasis. Our findings are important to clarify the role of estrogen in a critical period of testicular development, and to direct further studies, which may contribute to better understanding of the causes of male infertility.
INTRODUCTION
Estrogen plays an important role in male reproductive function and fertility [reviewed in 1, 2] . The testis of several mammals produces significant amounts of estrogen [reviewed in 3] via aromatase, which is biologically expressed in the rat testicular cells and represents the last step in the steroidogenic pathway. In rats, mRNA for aromatase is higher in Sertoli cells from 20-day-old than from 10-or 30-day-old animals. In adult rats, aromatase transcripts are undetectable in Sertoli cells, whereas the levels of aromatase in Leydig cells and pachytene spermatocytes are higher than the level in round spermatids [4; reviewed in 2]. In fact, Sertoli cells are the major source of estrogens in immature animals, although Leydig and germ cells synthesize these hormones in adult animals [reviewed in 2, 5] . In order to exert a biological effect, estrogens interact with the classical nuclear estrogen receptors (ESRs) ESR1 and ESR2 (also known as ERa and ERb) [reviewed in [6] [7] [8] [9] . The expression and distribution of these receptors in the different testicular cells have been extensively studied in mammals [reviewed in 1, 2, 10, 11] . In Sertoli cells from 15-day-old rats we have previously detected the presence of the Esr1 transcript and two splicing variants of Esr2, Esr2_v1, and Esr2_v2 [12] . A recent study described higher levels of Esr1 transcripts in Sertoli cells from 30-day-old rats than in 10-, 20-, and 70-dayold animals [4] . Although the level of Esr2 transcript does not change in Sertoli cells from 10-to 30-day-old rats, a significant increase is observed in Sertoli cells from 70-day-old animals. In the whole rat testis, Bois et al. [4] described the presence of Esr1 and one isoform with a deletion of exon 4, and the presence of Esr2 and three isoforms of Esr2. In adult rats, the level of Esr1 and Esr2 transcripts is higher in round spermatids than in pachytene spermatocytes.
The presence of ESR1 and ESR2 in the nuclei of cultured Sertoli cells obtained from 15-day-old rats was also detected in our laboratory [12] . In these cells, 17b-estradiol (E2) at physiological concentration activates a translocation of ESRs to the plasma membrane mediated by SRC (SRC family of tyrosine kinases), which results in the phosphorylation of epidermal growth factor receptor (EGFR) and mitogenactivated protein kinases (MAPK3/1, also known as ERK1/2). Moreover, activation of ESR1 and/or ESR2 by E2 is also involved in the proliferation of immature Sertoli cells (12) . The mitogenic effect of E2-ESRs triggers upregulation of cyclin D1 (CCND1) in these cells [13] . A recent study using estrogen nonresponsive ESR1 knock-in mice, which have a point mutation in the ligand-binding domain of ESR1 that significantly reduces interaction with endogenous estrogens without affecting ligand-independent ESR1 pathways mediated by growth factors, confirmed that estrogen-dependent ESR1 signaling is required for germ cell viability, most likely through support of Sertoli cell function [14] .
Several studies suggest that rapid responses to E2 can be mediated by ESRs present in/near the plasma membrane [reviewed in [8] [9] [15] [16] [17] and/or by G protein-coupled estrogen receptor 1 (GPER, or G protein-coupled receptor 30) [reviewed in [18] [19] . In fact, in the mouse spermatogonial GC-1 cell line, E2 rapidly activates the EGFR/MAPK3/1/FOS pathway through a cross-talk between GPER and ESR1, leading to cell proliferation [20] . In rat pachytene spermatocytes, E2 through both GPER and ESR1 is able to activate the EGFR/MAPK3/1/ JUN pathway, which in turn triggers an increase in the expression of the proapoptotic BCL2 family member BAX and a reduction of CCNA1 and CCNB1 [21] . In rat round spermatids, E2, GPER-selective agonist G-1, and ESR1-selective agonist 4,4 0 ,4 00 -(4-propyl-(1H)-pyrazole-1,3,5-triyl)-trisphenol (PPT) induce activation of EGFR/MAPK3/1, downregulation of the Ccnb1 mRNA, and upregulation of the Bax mRNA [22] . In rat Sertoli cells, GPER-mediated MAPK3/1 activation occurs via EGFR transactivation through G protein beta gamma subunits that promote SRC-mediated metalloprotease-dependent release of EGFR ligands, which bind to EGFR and lead to MAPK3/1 phosphorylation, which in turn triggers an increase the expression of antiapoptotic protein BCL2 and a decrease in the expression of proapoptotic protein BAX, indicating an antiapoptotic effect of E2-GPER in rat Sertoli cells [13] .
E2-evoked rapid signals involve the activation of several signal transduction pathways: for example, SRC/MAPKs as shown in testicular cells [12, 13, [20] [21] [22] ; phosphatidylinositol 3-kinase (PIK3)/serine threonine protein kinase (AKT); phospholipase C/protein kinase C (PKC); and janus kinase/ signal transducers and activators of transcription in several E2-sensitive cells; and some of these signaling pathways could be cell type specific [reviewed in 6-8, 17, 19] . E2 and growth factors, through the PIK3/AKT pathway, have also been shown to promote cell proliferation and survival in different tissues [23] [24] [25] [26] . In immature Sertoli cells, phosphorylation of AKT induced by follicle-stimulating hormone (FSH) increases the expression of aromatase and estradiol production [27] and lactate and transferrin production [28] . Thus far, the relative contribution of the PIK3/AKT pathway toward maintaining proliferation and survival through activation of ESRs and GPER in Sertoli cells has not been investigated.
In Sertoli cells, the cyclic AMP response element-binding (CREB) protein, a member of the CREB/CREM/ATF family of transcription factors, is an important transducer of FSH [29] and testosterone [30, 31] signals to induce gene expression. Activation of CREB in Sertoli cells plays an important role in spermatogenesis; overexpression of a CREB mutant in Sertoli cells in vivo results in apoptosis and elimination of germ cells [32] . This transcription factor binds as dimers to cyclic AMP response elements (CREs) within gene promoters, and, when phosphorylated on a specific serine, interacts with the CREB binding protein (CBP) coactivator, which contributes to the induction of gene transcription by facilitating the recruitment of general transcription factors and RNA polymerase to the promoter [33, 34] . E2-induced CREB phosphorylation at Ser133 through MAPK and PIK3 pathways plays a role in gene transcription in several cells [35] [36] [37] . The E2-mediated CREB phosphorylation has not been analyzed up to now in Sertoli cells.
In cultured immature rat Sertoli cells, the regulatory mechanisms that control cell proliferation (activation of ESRs) and antiapoptotic effect (activation of GPER) by E2 are remarkably overlapping through activation of EGFR/MAPK3/ 1 [12, 13] . However, several studies have shown that other intracellular signaling pathways take place downstream of ESRs and GPER to induce these actions in different cells [reviewed in 6-8, 17, 19] . Thus, the aim of the present study was to investigate the intracellular signaling events downstream of ESRs and GPER involved in regulation of proliferation and apoptosis of rat Sertoli cells.
MATERIALS AND METHODS

Sertoli Cell Culture
Primary cultures of Sertoli cell were obtained from 15-day-old male Wistar rats housed in the Animal Facility at Instituto de Farmacologia e Biologia Molecular, Escola Paulista de Medicina-Universidade Federal de São Paulo (EPM-UNIFESP), and maintained on a 12L:12D lighting schedule at 238C with food and water ad libitum. The experimental procedures were conducted according to guidelines for the care and use of laboratory animals as approved by the Research Ethical Committee (121/08) from EPM-UNIFESP. The testes were removed and decapsulated, and Sertoli cells were prepared as previously described [12, 13] . The cells (0.45 3 10 6 cells/ml) were plated at a density of 4 3 10 6 cells/9 ml in each 100-mm dish (about 5 3 10 4 cells/cm 2 ) to allow the formation of monolayer in phenol red-free Ham F12:Dulbecco modified Eagle medium (1:1; Gibco, Invitrogen) containing 0.02 g/L gentamicin (Sigma), pH 7.2-7.4, and supplemented with 10 lg/ml insulin, 10 lg/ml transferrin, 10 ng/ ml sodium selenite, and 10 ng/ml epidermal growth factor (EGF; Sigma). The cells were grown in a humidified atmosphere of 5% CO 2 :95% air at 358C and, after 48 h, they were treated with 20 mM Tris-HCL, pH 7.4, to lyse residual germ cells [38] , and allowed to grow for another 24 h. Culture medium was replaced by another one without supplements 20 h before the experiments with Sertoli cells. At this stage, the cells were 90%-95% confluent and viability was higher than 90%, as determined by trypan blue exclusion. The presence of other cell types in the primary culture of Sertoli cells was evaluated by several criteria, which confirmed the absolute predominance of Sertoli cells in the primary culture [12] .
Western Blot for Detection of AKT, Phospho-AKT, CCND1, BCL2, BCL2L2 (BCL-W), and BAX For detection of AKT and phospho-AKT, the cells were incubated in the absence (vehicle; control) and presence of E2 (0.1 nM; Sigma) or GPERselective agonist G-1 (1 nM; Calbiochem) for 5-60 min at 358C [12, 13] . E2 was prepared in ethanol (10 lM) and G-1 in dimethyl sulfoxide (10 mM) and diluted in PBS (137 mM NaCl, 2.68 mM KCl, 6.03 mM Na 2 HPO 4 , and 1.47 mM KH 2 PO 4 ; pH 7.4; Sigma). The cells were also untreated or pretreated with PIK3 inhibitor Wortmannin (1 lM; Sigma) for 30 min. Afterwards, the cells were stimulated with E2 (0.1 nM) or G-1 (1 nM) for 10 min. Medium was removed and the cells were washed with ice-cold PBS and lysed in ice-cold lysis buffer (20 mM HEPES, 150 mM NaCl, pH 7.5, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 1 mM ethylene glycol-bis (2-aminoethylether)-N,N,N 0 , N 0 -tetraacetic acid (EGTA), 1 lg/ml aprotinin, 1 lg/ml leupeptin, 1 mM PMSF, 2 mM Na 3 VO 4 , 50 mM NaF, 10 mM Na 4 P 2 0 7 ) [12] . Total cellular proteins (60 lg/lane) were incubated with sample buffer containing b-mercaptoethanol and subjected to 10% SDS/PAGE. Proteins were electrotransferred onto polyvinylidene fluoride (PVDF) membranes overnight, 20V at 48C. Membranes were blocked in Tris-buffered saline (TBS; 10 mM Tris, 150 mM NaCl) containing 0.2% Tween 20 (TBS-T) and 5% nonfat dry milk, pH 7.6, for 2 h at room temperature. After washes in TBS-T, membranes were incubated with a rabbit monoclonal antibody produced by immunizing animals with a synthetic peptide corresponding to residues in the C-terminal sequence of mouse AKT (AKT [pan], Cell Signaling Technology) or rabbit polyclonal antibody raised against Phospho-AKT Ser473 (p-AKT, Ser473, Cell Signaling Technology) diluted in blocking solution 1:4000 and 1:1000, respectively, overnight at 48C. Proteins were visualized, after incubation with donkey anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibody (GE) diluted 1:3000 for 1 h at room temperature, by enhanced chemiluminescence reagent (ECL; GE Healthcare U.K. Limited). Band intensities of total AKT and phosphorylated AKT from individual experiments were quantified by densitometric analysis of linear-range autoradiograms using an Epson Expression 1680 scanner (Epson America) and Quick Scan 2000 WIN software (Helena Laboratories). Results were normalized based on total AKT expression in each sample and plotted (mean 6 SEM) in relation to control (¼1).
For detection of CCND1, the cells were incubated in the absence (control) and presence of E2 (0.1 nM; Sigma), G1 (1 nM; Calbiochem) [12, 13] , ESR1-ROYER ET AL.
selective agonist PPT (10 nM; Tocris Bioscience), or ESR2-selective agonist 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN; 10 nM; Tocris Bioscience) [39] for 24 h at 358C. PPT and DPN were prepared in dimethyl sulfoxide (100 mM) and diluted in PBS. The cells were also untreated or pretreated with PIK3 inhibitor Wortmannin (1 lM; Sigma) or disruptor of the CREB:CBP complex KG-501 (25 lM; Sigma) for 30 min at 358C [40] [41] [42] . Afterwards, the cells were stimulated with E2 (0.1 nM; Sigma) for 24 h at 358C. Western blot assays for detection of CCND1 were performed as described by Lucas et al. [13] . Actin (ACT) levels were monitored on the same blot to ensure equal protein loading, by using a rabbit antibody raised against a synthetic peptide derived from residues 20-33 of ACT with N-terminus added lysine (1:4000; Sigma), overnight at 48C. Results were normalized to the respective ACT expression and plotted (mean 6 SEM) in relation to control (¼100%).
For detection of antiapoptotic proteins BCL2 and BCL2L2 and proapoptotic protein BAX, the cells were incubated in the absence (control) and presence of E2 (0.1 nM; Sigma) or G-1 (1 nM; Calbiochem) for 24 h at 358C. The cells were also untreated or pretreated with GPER antagonist (3aS*,4R*,9bR8)-4(bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b,3H-cyclopenta[c]-quinoline (G-15; 10 nM; Tocris Bioscience) for 30 min [43] , MAP2K1/2 inhibitor U0126 (20 lM; Cell Signaling Technology) for 30 min, EGFR kinase inhibitor AG1478 (4-(3-chloroanilino)-6,7-dimethoxyquinazoline; 50 lM; Calbiochem) for 15 min, PIK3 inhibitor Wortmannin (1 lM, Sigma) for 30 min, or disruptor of the CREB:CBP complex KG-501 (25 lM; Sigma) for 30 min. At these concentrations, the inhibitors are highly selective, as previously reported in Sertoli cells [12, 13, 31, 44] . Afterwards, cells were stimulated with E2 (0.1 nM; Sigma) or G-1 (1 nM; Calbiochem) for 24 h at 358C, and Western blot assays were performed as described by Lucas et al. [13] . Results were normalized to the respective ACT expression and plotted (mean 6 SEM) in relation to control (¼100%).
Apparent molecular masses were determined from molecular mass standards (New England Biolabs).
Western Blot for Detection of Phospho-CREB (Ser133)
Primary Sertoli cell cultures were incubated in the absence (control) and presence of E2 (0.1 nM; Sigma) or G-1 (1 nM; Calbiochem) for 5-180 min at 358C [12, 13] . Forskolin (10 lM, 5 min, 358C) (Sigma) was used as a control [29, 45] . In another series of experiments, the cells were untreated or pretreated with MAP2K1/2 inhibitor U0126 (20 lM; Cell Signaling Technology) for 30 min, EGFR kinase inhibitor AG1478 (50 lM; Calbiochem) for 15 min, PIK3 inhibitors Wortmannin (1 lM, Sigma) for 30 min and LY294,002 (20 lM, Sigma) for 60 min, ICI 182,780 (ICI; 1 nM, prepared diluting commercially available 0.1 M solution of fulvestrant; AstraZeneca) for 30 min, or G-15 (10 nM, prepared in dimethyl sulfoxide [50 mM ] and diluted in PBS; Tocris Bioscience) for 30 min, at 358C. Afterward, the cells were stimulated with E2 (0.1 nM) or G-1 (1 nM) for 10 min. Nuclear fractions were obtained as previously described by Arai et al. [46] . Briefly, the cells were washed with icecold PBS and lysed in ice-cold lysis buffer (10 mM Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.5% Nonidet P40, 1 mM PMSF, 2 mM Na 3 VO 4 , 50 mM NaF, 10 mM Na 2 P 2 O 7 , 1 lg/ml leupeptin, and 1 lg/ml aprotinin). The nuclei were separated using a buffer containing 1.0 M sucrose. The nuclear content was extracted with buffer containing 10 mM HEPES, 200 mM NaCl, pH 7.9, 1.5 mM MgCl 2 , 0.1 mM EDTA, 5% glycerol, 1 mM PMSF, 2 mM Na 3 VO 4 , 50 mM NaF, 10 mM Na 2 P 2 O 7 , 1 lg/ml leupeptin, and 1 lg/ml aprotinin.
Nuclear extracts (20 lg/lane) were incubated with sample buffer containing dithiothreitol, and subjected to 10% SDS/PAGE. Proteins were electrotransferred onto PVDF membranes overnight, 20V at 48C. Membranes were blocked in TBS-T containing 10% nonfat dry milk, pH 7.6, for 2 h at room temperature. After washes in TBS-T, membranes were incubated with a rabbit monoclonal antibody corresponding phospho-CREB Ser133 (Phospho-CREB [Ser 133], Cell Signaling Technology) diluted in blocking solution 1:1000, overnight at 48C. Proteins were visualized, after incubation with donkey antirabbit HRP-conjugated secondary antibody (Amersham Biosciences) diluted in TBS-T (1:3000) for 1 h at room temperature, by ECL. Lamin A, used as a nuclear protein loading control, was detected with a rabbit antibody raised against a synthetic peptide derived from residues 563-664 of lamin A (Santa Cruz Biotechnologies), overnight at 48C. Band intensities of phospho-CREB and lamin A from individual experiments were quantified as described above for AKT. Results were normalized to the respective lamin A expression and plotted (mean 6 SEM) in relation to control (¼1).
Lactate dehydrogenase detection was performed in cytoplasmic and nuclear fractions to estimate the contamination of the nuclear fraction with cytoplasm, according to manufacturer's instructions (Roche Applied Science). An average ratio of 0.094 was always obtained, indicating almost no contamination with cytoplasm. Furthermore, Western blot assays were performed for glycerol-3 phosphate dehydrogenase and b-tubulin in both fractions. Both proteins were detected only in cytoplasmic fraction (data not shown), indicating the purity of nuclear fraction.
Protein Assays
Protein concentration was determined with the Bio-Rad protein assay, using bovine serum albumin as standard (Bio-Rad Laboratories).
Statistical Analysis
Data were expressed as mean 6 SEM. Statistical analysis was carried out by Student t-test. P values , 0.05 were accepted as significant.
RESULTS
E2 and G-1 Induce AKT Phosphorylation in the Sertoli Cells
AKT activity and expression in Sertoli cell lysates were measured by immunoblotting using phosphorylation statedependent (top panels) and -independent (middle panels) antibodies (Fig. 1 ). The treatment with physiological concentration of E2 (0.1 nM) induced a rapid and transient increase in the AKT phosphorylation. The peak of AKT phosphorylation occurred at 5 min (1.9-fold increase compared with control) (Fig. 1A) . The AKT activity returned to control levels by 30 min (Fig. 1A) . PIK3 inhibitor Wortmannin blocked the AKT activation induced by E2 (Fig. 1A, inset) .
The GPER-selective agonist G-1 (1 nM) induced a less pronounced but also rapid and transient increase in the AKT phosphorylation. The peak of AKT phosphorylation induced by G-1 occurred at 10 min (0.8-fold increase compared with control) (Fig. 1B) . PIK3 inhibitor Wortmannin blocked the AKT activation induced by G-1 (Fig. 1B, inset) .
Pretreatment with Wortmannin for 30 min, in the absence of E2 or G-1, did not affect AKT phosphorylation (data not shown). No differences were observed in total AKT protein expression under any of these conditions (middle panels of Fig.  1A and 1B and bottom panels of insets).
The phosphorylation of AKT mediated by E2 was not blocked by MAP2K1/2 inhibitor U0126. Furthermore, the phosphorylation of MAPK3/1 mediated by E2 also was not blocked by PIK3 inhibitors Wortmannin and LY-294,002 (Supplemental Fig. S1 ; all Supplemental Data are available online at www.biolreprod.org).
E2 and G-1 Induce CREB Phosphorylation in the Sertoli Cells
The treatment with E2 (0.1 nM) induced a rapid and transient increase in the phosphorylation state of CREB in the Sertoli cells (Fig. 2, top panels) . The peak of CREB phosphorylation occurred at 10 min (3.2-fold increase compared with control) (Fig. 2A) . Forskolin was used as a positive control for activated CREB (Fig. 2A) . The activation of CREB induced by a 10-min treatment with E2 (0.1 nM) was only partially inhibited by pretreatment with ICI ( Fig. 2A,  inset) , suggesting that other receptors, besides ESR1 and ESR2, are also involved in the regulation of CREB. ICI for 30 min, in the absence of E2, did not affect CREB phosphorylation (data not shown).
The GPER-selective agonist G-1 (1 nM) also induced a rapid and transient increase in the phosphorylation state of CREB in the Sertoli cells. The peak of CREB phosphorylation occurred at 5 min (3.8-fold increase compared with control) (Fig. 2B) . The CREB activity returned to control levels by 30 min (Fig. 2B) . The activation of CREB induced by a 5-min treatment with G-1 (1 nM) was blocked by pretreatment with G-15 (Fig. 2B, inset) , suggesting the involvement of GPER. No 17BETA-ESTRADIOL SIGNALING IN RAT SERTOLI CELLS differences were observed in lamin A expression under any of these conditions (middle panels of Fig. 2A and 2B and insets) .
To further confirm the involvement of EGFR, MAPK3/1, and PIK3 in the phosphorylation of CREB induced by treatment with E2 (0.1 nM) or G-1 (1 nM), the EGFR kinase inhibitor (AG 1478), selective inhibitor of MAP2K1/2 (MEK1/2) (U0126), and PIK3 inhibitors (Wortmannin and LY-294,002) were tested. The activation of CREB induced by E2 or G-1 was blocked by pretreatment with U0126 (Fig. 3, A and B) and AG 1478 (Fig. 3, C and D) . The PIK3 inhibitors Wortmannin and LY294,002 also blocked the CREB phosphorylation induced by E2 (Fig. 3C) , but did not significantly change the CREB phosphorylation induced by G-1 (Fig. 3D) .
Pretreatment with U0126, AG 1478, Wortmannin, or LY-294,002, in the absence of E2 or G-1, did not have any effect on CREB phosphorylation (data not shown).
AKT, but Not CREB, Is Involved in the Expression of CCND1 Induced by E2-ESR1 in the Sertoli Cells
The treatment with E2 (0.1 nM, 24 h) increased the expression of CCND1 and the treatment with G-1 (1 nM, 24 h) did not change the expression of this protein (Fig. 4A) , confirming previous studies from our laboratory [12] . To further confirm the involvement of ESR1 and/or ESR2, the selective agonists were used. The treatment with ESR1-selective agonist PPT (10 nM, 24 h) increased the expression of CCND1, whereas the treatment with ESR2-selective agonist DPN (10 nM, 24 h) did not change the expression of this protein (Fig. 4A) , suggesting that ESR1 is the upstream receptor regulating Sertoli cell proliferation. E2-or PPTinduced CCND1 expression was blocked by pretreatment with the PIK3 inhibitor Wortmannin (Fig. 4, B and D) .
KG-501, the compound that disrupts the phospho-CREB/ CBP complex, did not change the expression of CCND1 induced by E2 (Fig. 4C) or PPT (Fig. 4D) , indicating that CREB is not involved in the expression of CCND1.
AKT, but Not CREB, Is Involved in the Expression of BCL2 and BCL2L2 Induced by E2-GPER
The treatment with E2 (0.1 nM, 24 h) or G-1 (1 nM, 24 h) increased the expression of the antiapoptotic protein BCL2, confirming previous studies from our laboratory [13] , and BCL2L2 (Fig. 5) . These effects were blocked by pretreatment with GPER antagonist G-15, indicating that GPER is the upstream component of this action (data not shown).
E2-or G-1-induced BCL2 and BCL2L2 expression was blocked by pretreatment with the PIK3 inhibitor Wortmannin (Fig. 5, A-C) . As previously reported for BCL2 [13] , the increase of BCL2L2 expression induced by E2 or G-1 was also blocked by pretreatment with the EGFR kinase inhibitor (AG 1478) and the selective inhibitor of MAP2K1/2 (U0126) (Supplemental Fig. S2 ).
Pretreatment with KG-501, disruptor of the phospho-CREB/ CBP complex, did not change the expression of BCL2 and BCL2L2 induced by E2 or G-1 (Fig. 5, D-F) , suggesting that CREB did not play a role in these effects.
CREB Is Involved in the Expression of BAX in the Sertoli Cells
The treatment with E2 (0.1 nM, 24 h) or G-1 (1 nM, 24 h) decreased the expression of the proapoptotic BAX (Fig. 6) , confirming previous studies from our laboratory [13] , and these effects were resistant to the PIK3 inhibitor Wortmannin (Fig. 6,   A and B) . On the other hand, pretreatment with the disruptor of the phospho-CREB/CBP complex KG-501 blocked the effects of E2 or G-1 in the expression of BAX (Fig. 6, C and D) .
DISCUSSION
Sertoli cell plays a key role in spermatogenesis, and a better knowledge about the role of hormones and growth factors in the regulation of the homeostasis and functions of Sertoli cell will be important for the control of male fertility. Our laboratory has studied the effects of E2 and its receptors in Sertoli cells from 15-day-old rats. We have shown that rapid (nongenomic) effects of E2 may occur through the translocation of ESR1 and ESR2 from the nucleus to the plasma membrane, and through the activation of the GPER. Both receptors promote phosphorylation of MAPK3/1 [12] [13] .
The activation of SRC-MAPK3/1 plays several important roles in Sertoli cell physiology. MAPK3/1 phosphorylation induced by FSH is involved in the regulation of Sertoli-Sertoli junctions, Sertoli-matrix anchoring junctions, and the tight junction barrier [47] . MAPK3/1 plays a role in adhesion between Sertoli and germ cells, especially at the apical ectoplasmic specialization, where MAPK3/1 and phosphorylated MAPK3/1 have been observed [48, 49] . The activation of SRC/MAPK3/1 induced by E2 regulates proteins involved in proliferation and apoptosis of Sertoli cells [13] . Testosteronemediated attachment of less mature germ cells to Sertoli cells requires activation of SRC and MAPK3/1, and activation of SRC is also required for release of mature sperm [50] , suggesting that these kinases could be important targets regulating male fertility.
Several studies have shown that E2 also induces activation of the PIK3/AKT signaling cascade in different cells [23] [24] [25] [26] . Although there are many downstream targets of PIK3, the AKT is a primary mediator of PIK3 regulating cellular components that affect cell survival [51] . In the present study, E2 and G-1, through stimulation of ESRs and GPER, also induce phosphorylation of AKT. This effect is blocked by PIK3 inhibitor Wortmannin. It is important to emphasize that the phosphorylation of AKT mediated by E2 or G-1 is not blocked by MAP2K1/2 inhibitor U0126. Furthermore, the phosphorylation of MAPK3/1 mediated by E2 or G-1 also is not blocked by PIK3 inhibitor. These data suggest that the effects of E2 on Sertoli cells may be mediated by two independent transduction pathways.
Several reports have established that E2 treatment results in the rapid phosphorylation of CREB at Ser133 by different kinases, such as MAPK3/1 and PIK3/AKT [36, 37, 52, 53] . Although E2 has been shown to increase cyclic AMP, it has been suggested that the cyclic AMP/protein kinase A (PKA) pathway may not be involved in estrogen-mediated CREB phosphorylation in vivo [54] . In Sertoli cells, E2 at nanomolar concentration phosphorylates CREB at Ser113 in a timedependent manner. It is important here to emphasize that, based on our data [12] , we pretreated the cells with ICI for 30 min to antagonize E2 effects on ESRs. No agonist activity of this compound on phosphorylation of MAPK3/1 has been detected after 30 min [13] . On the other hand, ICI through GPER stimulates phosphorylation of MAPK3/1 when incubated with cells for 10 min [13] . The activation of CREB induced by a 10-min treatment with E2 is only partially inhibited by pretreatment with ICI for 30 min, suggesting that, besides ESRs, other estrogen receptors are involved in the activation of CREB. Indeed, GPER-selective agonist G-1 also produces a rapid and transient increase in the phosphorylation state of CREB in the Sertoli cells. This effect is blocked by ROYER ET AL. 1 nM) (A, C, D, and F) or G-1 (1 nM) (B, C, E, and F) for 24 h. Cells were untreated or pretreated with inhibitor of PIK3 (Wortmaninn, 1 lM, 30 min) (A, B, and C) or a disruptor of the CREB:CBP complex (KG-501, 25 lM, 30 min) (D, E, and F). Afterwards, cells were stimulated with E2 (0.1 nM) or G-1 (1 nM) for 24 h. Total cell lysates (60 lg of protein/lane) were resolved in 15% SDS/PAGE, transferred to PVDF membrane, and probed with antibody specific for BCL2 or BCL2L2 (top panel) or with antibody that recognizes ACT (bottom panel). The data shown are representative of four independent experiments. Results were normalized to ACT expression in each sample and plotted (mean 6 SEM) in relation to C (¼100%). *Significantly different from control (P , 0.05, Student t-test). **Significantly different from E2 or G-1 (P , 0.05, Student-t test).
17BETA-ESTRADIOL SIGNALING IN RAT SERTOLI CELLS
CREB by this pathway in Sertoli cells seems to occur not only by androgen action [30] , but also by E2 action. Furthermore, the effect of E2 on CREB phosphorylation is also blocked by inhibition of PIK3. Similarly, in prostate cancer cells, E2 through both SRC/MAPK3/1 and PIK3 pathways induces CREB phosphorylation [36] . In Sertoli cells, the activation PIK3/AKT by different factors and hormones regulates the expression of aromatase and estradiol production [27] , lactate and transferrin production [28] , and also Sertoli-germ cell anchoring junction dynamics [57] . We now report the role of this intracellular signaling on E2-mediated CREB phosphorylation. This transcript factor may be important for both Sertoli and germ cells. In fact, immunohistochemical analysis demonstrated the change of CREB phosphorylation in several testicular cells, including Sertoli cells, during postnatal development of mice [58] . CREB is required for the survival of spermatocytes and the subsequent production of spermatids [32] .
Many signaling pathways, including the MAPK and PIK3 pathways, regulate CCND1 expression [reviewed in 59, 60] . In Sertoli cells, E2 through activation of SRC/EGFR/MAPK3/1 [13] and PIK3 pathways induces upregulation of CCND1. It is important to emphasize that ESR1 is involved in this regulation, but not ESR2 or GPER. The precise mechanism for CCND1 gene regulation by E2 is not fully understood. The CCND1 promoter contains multiple regulatory elements: E2F, Oct, Sp1, AP-1, CRE, and some potential elements that may be involved in the transcriptional regulation of the gene. Furthermore, no ERE-related sequence has been identified in the proximal CCND1 promoter [61, 62] . In Sertoli cells, KG-501, the compound that disrupts the phospho-CREB/CBP complex [40] , does not change the E2-ESR1-mediated CCND1 expression, suggesting that phospho-CREB/CRE/CBP is not involved in the expression of this protein. It remains to be determined whether E2-ESR1 in Sertoli cells directly and/or through their intracellular signaling pathways can activate other transcription factors, such as Sp1 and AP-1, involved in the regulation of CCND1 expression. In some cell types, both transcription factors are important to modulate expression of a large number of genes, including CCND1 [reviewed in 7] . AP-1 family members such as FOS (c-fos) in spermatogonia [20] and JUN (c-jun) in spermatocytes [21] are rapidly activated by E2-ESR1 and E2-GPER cross-talk through EGFR/MAPK3/1. CCND1 regulates cell proliferation, cell growth, and differentiation by binding representatives of several transcription factor families, including members of the steroid hormone receptor superfamily and their coregulators [reviewed in 60]. CCND1 enhances ESR1 activity through interactions with ESR1 and its coregulators SRC1 (NCOA1) and AIB1 (NCOA3). In contrast, CCND1 inhibits the activity of the androgen receptor, thyroid hormone receptor-b, and peroxisome proliferator activated receptor-c [reviewed in 60]; MYBL2 (BMYB) and the MYB-related transcription factor DMP1; and the helix-loop-helix transcription factors neurogenic differentiation factor 1, MYOD, and CEBPB (C-EBP) [reviewed in 63, 64] . In addition, CCND1 binds chromatinmodifying enzymes, including histone acetyltransferases such as P/CAF (KAT2B) [65] , p300/CBP (CREBBP) [66] , and histone deacetylases [67] . All these mechanisms mediated by CCND1 remain to be determined in Sertoli cells.
Study in our laboratory showed that GPER, but not ESRs, plays a role modulating gene expression involved with apoptosis in rat Sertoli cells. The activation of this receptor triggers an increase in the expression of antiapoptotic protein BCL2 and a decrease in the expression of proapoptotic protein BAX [13] . In Sertoli cells from 20-day-old rat, the expression of antiapoptotic protein BCL2 is very low when compared with BCL2L2, also a member of the BCL2 family of apoptosisregulating proteins [68] . The steady-state levels of BCL2L2 mRNA and protein are higher in Sertoli cells than in spermatogonia and spermatocytes. FSH upregulates the BCL2L2 transcript in vitro, and no change is observed with testosterone [69] . Furthermore, male Bcl2l2-deficient mice are sterile because of a development arrest and progressive loss of germ cells and Sertoli cells from the testis [70] [71] [72] . Mice Sertoli cells require BCL2L2 in a cell-intrinsic manner for long-term survival. In situ hybridization analysis indicates that BCL2L2 is expressed in mouse Sertoli cells before and after exit from mitosis. Therefore, BCL2L2 independent pathways promote the survival of undifferentiated mitotic Sertoli cells [73] . These data show the role of BCL2L2 in regulation of apoptosis in Sertoli cells and germ cells. Thus, in the present study, the effects of E2 or G-1 on the expression of both BCL2 and BCL2L2 were analyzed. The activation of GPER also triggers an increase in the expression of antiapoptotic protein BCL2L2. Together, these results point to an antiapoptotic effect of E2 in Sertoli cells.
The activation of EGFR/MAPK3/1 and PIK3 pathways may be involved in the upregulation of BCL2 and BCL2L2 induced by activation of GPER. E2 may enhance BCL2 expression and prevent H 2 O 2 -induced apoptosis by phosphorylating CREB in keratinocytes [74] . Furthermore, a CRE present within the BCL2 promoter [75] is targeted by IGF1 via AKT and CREB phosphorylation [76, 77] . However, in Sertoli cells GPERmediated upregulation of BCL2 and BCL2L2 is not mediated by phospho-CREB/CRE/CBP. Similar results were observed in neuronal nuclei of the cerebral cortex of newborn piglets [78] . It is important to emphasize that mutation of the consensus AKT site or of potential PKC or PKA sites into BCL2 does not affect the stability of BCL2. In contrast, inactivation of the three consensus MAPK3/1 sites leads to BCL2 protein ubiquitination and subsequently degradation by the 26S proteasome [79, 80] . It remains to be investigated whether E2 through MAPK3/1 may induce phosphorylation of the putative MAP kinase sites of the BCL2 protein in Sertoli cells, blocking its degradation. Preliminary experiment showed that the upregulation of BCL2 expression by E2-GPER does not seem to involve de novo synthesis (data not shown), but rather regulation of degradation. Taken together, the EGFR/MAPK3/1 pathway plays an important role in the regulation of BCL2 and BCL2L2 mediated by E2 in Sertoli cells.
The EGFR/MAPK3/1 pathway is also involved in the decrease of BAX expression induced by activation of GPER [13] . On the other hand, the PIK3 pathway does not play a role in this regulation. Cerebral hypoxia increases phosphorylation of CREB in neuronal nuclei of the cerebral cortex of newborn piglets. A strong correlation has been shown between CREB phosphorylation and the expression of proapoptotic proteins BAX and BAD [78] . In Sertoli cells, the phospho-CREB/CRE/ CBP plays a role in the decrease of BAX expression induced by activation of GPER.
The present results show a differential effect of E2-GPER on the CREB-mediated transcription of a proapoptotic gene (Bax) and antiapoptotic genes (Bcl2, Bcl2l2) of the same BCL2 gene family. It is quite interesting to note how E2 can have such a selective effect on transcription mediated by CREB in the Sertoli cells. CREB phosphorylation has been linked to the activation of Sertoli cell genes that potentially contribute to germ cell development and survival [32, 81] . BAX expression is normally seen in germ cells and plays a role on spermatogenesis [reviewed in 82] .
In immature rat Sertoli cells, FSH induces activation of PIK3/AKT and an increase in the expression of aromatase and secretion of estradiol, whereas EGF induces activation of MAPK3/1 and inhibits FSH-induced aromatase expression [27] . It is important to emphasize that in our study E2-ESR1 and E2-GPER through both MAPK3/1 and PIK3/AKT pathways induce proliferative and antiapoptotic effects in these 17BETA-ESTRADIOL SIGNALING IN RAT SERTOLI CELLS cells. Whether activation of these pathways by E2 plays a role in the regulation of aromatase expression and secretion of estradiol by FSH remains to be determined.
In conclusion, these results indicate that in cultured Sertoli cells from 15-day-old rats, 1) E2-ESRs and E2-GPER induce CREB activation; 2) E2-ESR1 through two different pathways (MAPK and PIK3) plays a role in regulation of gene expression involved with proliferation; 3) E2-GPER through MAPK and PIK3 may regulate expression of the antiapoptotic proteins BCL2 and BCL2L2; and 4) E2-GPER through EGFR/ MAPK3/1/phospho-CREB may regulate the proapoptotic protein BAX. ESR1 and GPER can mediate the rapid E2 actions in the Sertoli cells, which in turn can modulate nuclear transcriptional events important for Sertoli cell function and maintenance of normal testis development and homeostasis. Our findings are important to clarify the role of estrogen in critical period of testicular development, and to direct further studies, which may contribute to better understanding of the causes of male infertility.
